Perceptive Advisors - Q2 2017 holdings

$1.99 Billion is the total value of Perceptive Advisors's 126 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 59.3% .

 Value Shares↓ Weighting
FOLD  AMICUS THERAPEUTICS INC$174,178,000
+41.2%
17,296,6720.0%8.76%
+24.8%
NBIX BuyNEUROCRINE BIOSCIENCES INC$164,569,000
+12.9%
3,577,589
+6.3%
8.28%
-0.3%
ALNY BuyALNYLAM PHARMACEUTICALS INC$146,181,000
+158.5%
1,832,761
+66.1%
7.36%
+128.3%
GBT BuyGLOBAL BLOOD THERAPEUTICS IN$107,592,000
-24.3%
3,933,927
+1.9%
5.41%
-33.2%
VSAR  VERSARTIS INC$76,907,000
-18.3%
4,407,3170.0%3.87%
-27.8%
LJPC BuyLA JOLLA PHARMACEUTICAL CO$64,214,000
+0.6%
2,157,011
+0.8%
3.23%
-11.2%
PBYI NewPUMA BIOTECHNOLOGY INC$64,092,000733,320
+100.0%
3.22%
RTRX SellRETROPHIN INC$51,816,000
-0.0%
2,672,309
-4.8%
2.61%
-11.7%
TSRO BuyTESARO INC$50,287,000
+35.6%
359,551
+49.2%
2.53%
+19.7%
ZGNX BuyZOGENIX INC$50,000,000
+109.2%
3,448,302
+56.5%
2.52%
+84.7%
CORI BuyCORIUM INTL INC$43,620,000
+293.1%
5,847,133
+120.3%
2.20%
+247.3%
NXTM SellNXSTAGE MEDICAL INC$38,997,000
-20.1%
1,555,523
-14.4%
1.96%
-29.4%
DOVA NewDOVA PHARMACEUTICALS INC$38,037,0001,706,499
+100.0%
1.91%
SRPT SellSAREPTA THERAPEUTICS$36,743,000
-29.9%
1,089,961
-38.5%
1.85%
-38.1%
VRTX SellVERTEX PHARMACEUTICALS INC$35,742,000
+11.4%
277,352
-5.5%
1.80%
-1.6%
IOVA NewIOVANCE BIOTHERAPEUTICS INC$32,068,0004,363,114
+100.0%
1.61%
RDUS SellRADIUS HEALTH INC$29,212,000
-17.0%
645,873
-29.1%
1.47%
-26.7%
VBIV  VBI VACCINES IN$28,561,000
-20.8%
6,565,8430.0%1.44%
-30.0%
XNCR SellXENCOR INC$27,297,000
-29.0%
1,293,095
-19.5%
1.37%
-37.3%
EVH SellEVOLENT HEALTH INCcl a$27,234,000
-15.5%
1,074,327
-25.6%
1.37%
-25.3%
RGNX SellREGENXBIO INC$27,080,000
+0.5%
1,371,186
-1.8%
1.36%
-11.2%
QTNT BuyQUOTIENT LTD$26,010,000
+27.7%
3,714,486
+27.3%
1.31%
+12.8%
ANAB BuyANAPTYSBIO INC$22,788,000
-6.9%
952,269
+8.0%
1.15%
-17.7%
BPMC SellBLUEPRINT MEDICINES CORP$22,530,000
+22.0%
444,661
-3.7%
1.13%
+7.8%
AVXS SellAVEXIS INC$22,280,000
-34.7%
271,181
-39.5%
1.12%
-42.3%
SAGE BuySAGE THERAPEUTICS INCcall$21,901,000
+1014.0%
275,000
+37.5%
1.10%
+883.9%
XLRN BuyACCELERON PHARMA INC$21,615,000
+23.0%
711,259
+7.1%
1.09%
+8.7%
CTMX SellCYTOMX THERAPEUTICS INC$21,550,000
-18.5%
1,390,381
-9.2%
1.08%
-28.0%
DBVT  DBV TECHNOLOGIES S Asponsored adr$21,131,000
+1.4%
591,7650.0%1.06%
-10.4%
KDMN  KADMON HLDGS INC$20,172,000
+7.5%
5,185,8470.0%1.02%
-5.1%
ISRG NewINTUITIVE SURGICAL INC$19,357,00020,695
+100.0%
0.97%
HUM BuyHUMANA INC$18,791,000
+231.5%
78,093
+184.0%
0.95%
+192.9%
ALBO NewALBIREO PHARMA INC$17,407,000845,000
+100.0%
0.88%
GLPG SellGALAPAGOS NVspon adr$17,325,000
-25.9%
226,405
-16.6%
0.87%
-34.6%
SELB BuySELECTA BIOSCIENCES INC$15,834,000
+679.2%
797,325
+462.0%
0.80%
+587.1%
AKBA BuyAKEBIA THERAPEUTICS INC$15,808,000
+3359.1%
1,100,000
+2116.7%
0.80%
+2957.7%
AVDL BuyAVADEL PHARMACEUTICALS PLCsponsored adr$15,763,000
+15.6%
1,429,114
+1.5%
0.79%
+2.1%
MYOK SellMYOKARDIA INC$14,492,000
+76.4%
553,154
-11.5%
0.73%
+55.8%
ATRS BuyANTARES PHARMA INC$13,741,000
+65.9%
4,267,253
+46.3%
0.69%
+46.4%
BOLD BuyAUDENTES THERAPEUTICS INC$13,534,000
+10473.4%
707,500
+9333.3%
0.68%
+9628.6%
ALDX  ALDEYRA THERAPEUTICS INC$13,417,000
+4.0%
2,885,4580.0%0.68%
-8.2%
AVEO BuyAVEO PHARMACEUTICALS INC$13,343,000
+342.7%
6,010,660
+17.7%
0.67%
+290.1%
JAZZ BuyJAZZ PHARMACEUTICALS PLC$13,306,000
+205.6%
85,572
+185.2%
0.67%
+170.2%
AXGT BuyAXOVANT SCIENCES LTD$13,281,000
+186.8%
572,700
+84.7%
0.67%
+153.0%
WVE SellWAVE LIFE SCIENCES LTD$12,328,000
-32.6%
662,798
-0.4%
0.62%
-40.5%
IRTC BuyIRHYTHM TECHNOLOGIES INC$12,019,000
+17.9%
282,857
+4.4%
0.60%
+4.1%
ZYNE NewZYNERBA PHARMACEUTICALS INCput$10,164,000100,000
+100.0%
0.51%
ARGX NewARGENX SEsponsored adr$9,544,000450,000
+100.0%
0.48%
ARDX SellARDELYX INC$9,233,000
-61.3%
1,810,581
-4.0%
0.46%
-65.8%
ASMB SellASSEMBLY BIOSCIENCES INC$9,124,000
-46.1%
441,833
-33.5%
0.46%
-52.4%
RDUS BuyRADIUS HEALTH INCput$9,046,000
+1487.0%
200,000
+1940.8%
0.46%
+1321.9%
CSU SellCAPITAL SR LIVING CORP$8,064,000
-0.3%
530,173
-7.8%
0.41%
-11.9%
ACRX SellACELRX PHARMACEUTICALS INC$8,022,000
-52.9%
3,731,342
-31.0%
0.40%
-58.4%
 ANI PHARMACEUTICALS INCnote 3.000%12/0$7,908,000
-0.6%
7,500,0000.0%0.40%
-12.1%
EGRX NewEAGLE PHARMACEUTICALS INC$7,889,000100,000
+100.0%
0.40%
CRBP SellCORBUS PHARMACEUTICALS HLDGS$7,764,000
-24.7%
1,232,500
-1.4%
0.39%
-33.4%
AXGT BuyAXOVANT SCIENCES LTDcall$6,957,000
+389.9%
300,000
+50.0%
0.35%
+332.1%
QURE SellUNIQURE NV$6,748,000
-7.8%
1,090,119
-13.9%
0.34%
-18.5%
VIVE SellVIVEVE MED INC$6,394,000
+7.6%
890,468
-5.1%
0.32%
-4.7%
RARE NewULTRAGENYX PHARMACEUTICAL INcall$6,211,000100,000
+100.0%
0.31%
NVTA BuyINVITAE CORP$6,209,000
+17.0%
649,500
+35.3%
0.31%
+3.3%
ZYME NewZYMEWORKS INC$6,101,000730,768
+100.0%
0.31%
ANIP SellANI PHARMACEUTICALS INC$5,869,000
-53.5%
125,399
-50.8%
0.30%
-59.0%
CLSD SellCLEARSIDE BIOMEDICAL INC$5,649,000
-0.1%
620,181
-12.9%
0.28%
-11.8%
UNH BuyUNITEDHEALTH GROUP INC$5,281,000
+147.7%
28,480
+119.1%
0.27%
+119.8%
FOMX SellFOAMIX PHARMACEUTICALS LTD$5,184,000
-20.8%
1,117,324
-15.5%
0.26%
-30.0%
URGN NewUROGEN PHARMA LTD$4,858,000269,014
+100.0%
0.24%
ABEOW  ABEONA THERAPEUTICS INC*w exp 12/24/201$4,285,000
+16.1%
1,259,6360.0%0.22%
+2.9%
SRRA SellSIERRA ONCOLOGY INC$4,277,000
-24.5%
3,655,186
-1.3%
0.22%
-33.4%
FWP SellFORWARD PHARMA A/Ssponsored adr$3,959,000
-48.1%
194,718
-45.0%
0.20%
-54.3%
NEPT  NEPTUNE TECHNOLOGIES BIORESO$3,801,000
-17.5%
6,519,6340.0%0.19%
-27.4%
EXAS SellEXACT SCIENCES CORP$3,537,000
-63.5%
100,000
-75.6%
0.18%
-67.8%
PFNX SellPFENEX INC$3,392,000
-34.6%
845,973
-5.2%
0.17%
-42.0%
HSGX  HISTOGENICS CORP$3,182,000
+3.5%
1,777,7770.0%0.16%
-8.6%
BHVN NewBIOHAVEN PHARMACTL HLDG CO L$3,000,000120,000
+100.0%
0.15%
ADMA  ADMA BIOLOGICS INC$2,769,000
-21.3%
721,1020.0%0.14%
-30.5%
ABEO SellABEONA THERAPEUTICS INC$2,706,000
-13.1%
422,873
-32.1%
0.14%
-23.2%
OCRX SellOCERA THERAPEUTICS INC$2,365,000
-16.0%
2,038,880
-5.2%
0.12%
-25.6%
VRNA NewVERONA PHARMA PLCsponsored ads$2,331,000200,000
+100.0%
0.12%
XENE  XENON PHARMACEUTICALS INC$2,280,000
-21.2%
723,8530.0%0.12%
-30.3%
MGCD SellMGC DIAGNOSTICS CORP$2,140,000
-15.2%
252,327
-16.5%
0.11%
-25.0%
BLUE BuyBLUEBIRD BIO INC$2,101,000
+397.9%
20,000
+330.7%
0.11%
+341.7%
ADMP NewADAMIS PHARMACEUTICALS CORP$2,080,000400,000
+100.0%
0.10%
PSDV SellPSIVIDA CORP$1,966,000
-49.9%
1,149,556
-49.6%
0.10%
-55.6%
CRIS BuyCURIS INC$1,798,000
+29.4%
951,201
+90.2%
0.09%
+13.9%
BCLI NewBRAINSTORM CELL THERAPEUTICS$1,660,000400,000
+100.0%
0.08%
ALQA  ALLIQUA BIOMEDICAL INC$1,566,000
-26.7%
4,233,9510.0%0.08%
-35.2%
CARA NewCARA THERAPEUTICS INCcall$1,539,000100,000
+100.0%
0.08%
ARWR  ARROWHEAD PHARMACEUTICALS IN$1,372,000
-12.4%
847,4580.0%0.07%
-22.5%
AFMD SellAFFIMED N V$1,369,000
-18.9%
668,214
-9.0%
0.07%
-28.1%
EIGR  EIGER BIOPHARMACEUTICALS INC$1,245,000
-31.0%
157,6790.0%0.06%
-38.8%
EXEL  EXELIXIS SHARES$1,142,000
+13.6%
46,3610.0%0.06%0.0%
LNTH  LANTHEUS HLDGS INC$949,000
+41.2%
53,7630.0%0.05%
+26.3%
OSUR BuyORASURE TECHNOLOGIES INC$945,000
+55.2%
54,729
+16.1%
0.05%
+37.1%
CSBR BuyCHAMPIONS ONCOLOGY INC$943,000
-18.9%
366,973
+0.0%
0.05%
-28.8%
AZRX  AZURRX BIOPHARMA INC$916,000
+4.4%
227,2720.0%0.05%
-8.0%
WCG SellWELLCARE HEALTH PLANS INC$908,000
+22.5%
5,056
-4.3%
0.05%
+9.5%
ONS SellONCOBIOLOGICS INC$837,000
-73.6%
837,886
-29.1%
0.04%
-76.7%
OXFD NewOXFORD IMMUNOTEC GLOBAL PLC$741,00044,106
+100.0%
0.04%
LHCG BuyLHC GROUP INC$728,000
+184.4%
10,730
+126.1%
0.04%
+146.7%
HSKA BuyHESKA CORP$745,000
+12.7%
7,300
+15.9%
0.04%
-2.6%
INCY  INCYTE CORP$707,000
-5.9%
5,6190.0%0.04%
-16.3%
EW NewEDWARDS LIFESCIENCES CORP$719,0006,088
+100.0%
0.04%
ZSAN  ZOSANO PHARMA CORP$705,000
-25.8%
500,0000.0%0.04%
-35.2%
FCAU  FIAT CHRYSLER AUTOMOBILES N$659,000
-2.8%
62,0000.0%0.03%
-15.4%
HRC  HILL ROM HLDGS INC$631,000
+12.7%
7,9300.0%0.03%0.0%
ACOR NewACORDA THERAPEUTICS INC$626,00031,786
+100.0%
0.03%
CNC  CENTENE CORP DEL$617,000
+12.0%
7,7260.0%0.03%0.0%
AKAOQ BuyACHAOGEN INC$599,000
+1.0%
27,551
+17.3%
0.03%
-11.8%
VNDA  VANDA PHARMACEUTICALS INC$591,000
+16.6%
36,2320.0%0.03%
+3.4%
MOH NewMOLINA HEALTHCARE INC$563,0008,140
+100.0%
0.03%
RACE  FERRARI N V$533,000
+15.6%
6,2000.0%0.03%
+3.8%
PRTO  PROTEON THERAPEUTICS INC$518,000
-11.5%
334,1160.0%0.03%
-21.2%
ICLR NewICON PLC$507,0005,187
+100.0%
0.03%
INCR NewINC RESH HLDGS INCcl a$499,0008,532
+100.0%
0.02%
CDTX SellCIDARA THERAPEUTICS INC$465,000
-92.8%
62,110
-92.5%
0.02%
-93.7%
DPLO NewDIPLOMAT PHARMACY INC$454,00030,658
+100.0%
0.02%
PTLA SellPORTOLA PHARMACEUTICALS INC$442,000
-80.5%
7,870
-86.4%
0.02%
-82.9%
VYGR NewVOYAGER THERAPEUTICS INC$310,00034,604
+100.0%
0.02%
CUTR SellCUTERA INC$310,000
-37.5%
11,981
-50.0%
0.02%
-42.9%
NewPERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0$282,0001,000,000
+100.0%
0.01%
ACST  ACASTI PHARMA INC$247,000
-2.8%
186,5590.0%0.01%
-14.3%
ARNI  ARNO THERAPEUTICS INC$208,000
-18.1%
4,177,5770.0%0.01%
-28.6%
ONSIW  ONCOBIOLOGICS INCw exp 02/18/201$80,000
-78.4%
462,5000.0%0.00%
-81.0%
ONSIZ  ONCOBIOLOGICS INC*w exp 05/18/201$42,000
-81.8%
462,5000.0%0.00%
-84.6%
PPHM  PEREGRINE PHARMACEUTICALS IN$15,000
-6.2%
24,3320.0%0.00%0.0%
IWS ExitISHARES RUSSELL MID-CAP VALUE ETF$0-2
-100.0%
0.00%
ACHC ExitACADIA HEALTHCARE COMPANY SHARES$0-1
-100.0%
0.00%
TCON ExitTRACON PHARMACEUTICALS SHARES$0-50
-100.0%
0.00%
TLT ExitISHARES 20 PLUS YEAR TREASURY BOND ETFnote$0-2
-100.0%
0.00%
XIV ExitCREDIT SUISSE VELOCITYSHARES DAILY INVERSE VIX SHORT TERM ET$0-16
-100.0%
0.00%
ATRC ExitATRICURE SHARES$0-55
-100.0%
0.00%
AGRX ExitAGILE THERAPEUTICS SHARES$0-42
-100.0%
0.00%
IVV ExitISHARES CORE SandP 500 ETF$0-1
-100.0%
0.00%
BSX ExitBOSTON SCIENTIFIC SHARES$0-3
-100.0%
0.00%
CASC ExitCASCADIAN THERAPEUTICS SHARES$0-1,966
-100.0%
0.00%
DHR ExitDANAHER SHARES$0-3
-100.0%
0.00%
GNMX ExitAEVI GENOMIC MEDICINE SHARES$0-940
-100.0%
0.00%
APVO ExitAPTEVO THERAPEUTICS SHARES$0-450
-100.0%
0.00%
CRY ExitCRYOLIFE SHARES$0-123
-100.0%
0.00%
FPRX ExitFIVE PRIME THERAPEUTICS SHARES$0-127
-100.0%
0.00%
OPHT ExitOPHTHOTECH SHARES$0-1,600
-100.0%
0.00%
NPCUF ExitALLON THERAPEUTICS SHARES$0-751,124
-100.0%
0.00%
TNGNQ ExitTENGION INC$0-1,826,399
-100.0%
0.00%
CERS ExitCERUS SHARES$0-740
-100.0%
0.00%
TXMD ExitTHERAPEUTICSMD SHARES$0-1,081
-100.0%
0.00%
OBLN ExitOBALON THERAPEUTICS SHARES$0-4
-100.0%
0.00%
WST ExitWEST PHARMACEUTICAL SERVICES SHARES$0-138
-100.0%
-0.00%
CBPO ExitCHINA BIOLOGIC PRODUCTS SHARES$0-236
-100.0%
-0.00%
CLDX ExitCELLDEX THERAPEUTICS SHARES$0-6,970
-100.0%
-0.00%
ExitSEVION THERAPEUTICS INC$0-59,220
-100.0%
-0.00%
AGEN ExitAGENUS SHARES$0-3,600
-100.0%
-0.00%
CAPR ExitCAPRICOR THERAPEUTICS SHARES$0-4,000
-100.0%
-0.00%
ABBV ExitABBVIE SHARES$0-380
-100.0%
-0.00%
BMRN ExitBIOMARIN PHARMACEUTICAL SHARES$0-250
-100.0%
-0.00%
ABT ExitABBOTT LABORATORIES SHARES$0-415
-100.0%
-0.00%
EPZM ExitEPIZYME SHARES$0-1,165
-100.0%
-0.00%
ADHD ExitALCOBRA SHARES$0-9,109
-100.0%
-0.00%
AGLE ExitAEGLEA BIOTHERAPEUTICS SHARES$0-5,833
-100.0%
-0.00%
RCM ExitR1 RCM SHARES$0-17,976
-100.0%
-0.00%
RXDX ExitIGNYTA SHARES$0-6,584
-100.0%
-0.00%
EVH ExitEVOLENT HEALTH INC SHARES -A- CALL 20 06/16/2017call$0-50,000
-100.0%
-0.01%
ARRY ExitARRAY BIOPHARMA SHARES$0-25,510
-100.0%
-0.01%
ExitPERNIX THERAPEUTICS HOLD 01APR21 4.25PCT$0-1,000,000
-100.0%
-0.02%
QHCCQ ExitQUORUM HEALTH SHARES$0-50,604
-100.0%
-0.02%
EARS ExitAURIS MEDICAL HOLDING SHARES$0-400,000
-100.0%
-0.02%
ANTM ExitANTHEM SHARES$0-3,081
-100.0%
-0.03%
PAHC ExitPHIBRO ANIMAL HEALTH SHARES CLASS A$0-18,382
-100.0%
-0.03%
QSII ExitQUALITY SYSTEMS SHARES$0-33,875
-100.0%
-0.03%
MCK ExitMCKESSON SHARES$0-3,601
-100.0%
-0.03%
CBM ExitCAMBREX SHARES$0-9,515
-100.0%
-0.03%
HMSY ExitHMS HOLDINGS SHARES$0-26,553
-100.0%
-0.03%
MDRX ExitALLSCRIPTS HEALTHCARE SOLUTIONS SHARES$0-42,955
-100.0%
-0.03%
PRAH ExitPRA HEALTH SCIENCES SHARES$0-8,308
-100.0%
-0.03%
MASI ExitMASIMO SHARES$0-5,945
-100.0%
-0.03%
ILMN ExitILLUMINA SHARES$0-3,500
-100.0%
-0.03%
MTST ExitMETASTAT SHARES$0-500,000
-100.0%
-0.04%
AKRXQ ExitAKORN SHARES$0-40,000
-100.0%
-0.06%
BLCM ExitBELLICUM PHARMACEUTICALS SHARES$0-86,200
-100.0%
-0.06%
BCLI ExitBRAINSTORM CELL THERAPEUTICS INC SHARES (OLD)$0-400,000
-100.0%
-0.10%
IMMU ExitIMMUNOMEDICS SHARES$0-300,060
-100.0%
-0.11%
RARX ExitRA PHARMACEUTICALS SHARES$0-100,000
-100.0%
-0.12%
AERI ExitAERIE PHARMACEUTICALS SHARES$0-50,000
-100.0%
-0.13%
AMGN ExitAMGEN SHARES$0-20,000
-100.0%
-0.19%
DERM ExitDERMIRA SHARES$0-115,583
-100.0%
-0.22%
PPHMP ExitPEREGRINE PHARMACEUTICALS INC 10.5$0-200,000
-100.0%
-0.25%
SGYPQ ExitSYNERGY PHARMACEUTICALS SHARES$0-978,100
-100.0%
-0.26%
ZYNE ExitZYNERBA PHARMACEUTICALS INC$0-251,328
-100.0%
-0.29%
NERV ExitMINERVA NEUROSCIENCES INC$0-810,537
-100.0%
-0.37%
ALDR ExitALDER BIOPHARMACEUTICALS SHARES$0-384,169
-100.0%
-0.46%
BIO ExitBIO RAD LABORATORIES SHARES CLASS A$0-49,416
-100.0%
-0.56%
CLVS ExitCLOVIS ONCOLOGY SHARES$0-157,754
-100.0%
-0.57%
ABMD ExitABIOMED SHARES$0-85,000
-100.0%
-0.61%
AMAG ExitAMAG PHARMACEUTICALS SHARES$0-560,000
-100.0%
-0.72%
NVRO ExitNEVRO SHARES$0-217,292
-100.0%
-1.16%
LBIO ExitLION BIOTECHNOLOGIES SHARES$0-3,567,553
-100.0%
-1.51%
ACRS ExitACLARIS THERAPEUTICS SHARES$0-1,260,847
-100.0%
-2.14%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-08-14
Signatures

The EDGAR filing(s) were signed by:

About Perceptive Advisors

Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.

The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.

One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.

Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NEUROCRINE BIOSCIENCES SHARES42Q3 202315.7%
AMICUS THERAPEUTICS SHARES39Q3 202314.0%
ALDEYRA THERAPEUTICS SHARES35Q3 20233.3%
QUOTIENT TECHNOLOGY INC34Q3 20222.7%
GLOBAL BLOOD THERAPEUTICS SHARES29Q3 20229.3%
ADMA BIOLOGICS SHARES29Q3 20231.4%
RETROPHIN SHARES28Q3 20205.5%
DBV TECHNOLOGIES SA-SPON ADR28Q3 20211.8%
VBI VACCINES SHARES27Q1 20232.8%
IOVANCE BIOTHERAPEUTICS INC26Q3 20239.1%

View Perceptive Advisors's complete holdings history.

Latest significant ownerships (13-D/G)
Perceptive Advisors Q2 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CHEMBIO DIAGNOSTICS, INC.Sold outMay 04, 202300.0%
VBI Vaccines Inc/BCApril 07, 202343,509,55316.7%
Landos Biopharma, Inc.March 30, 202314,869,91547.7%
REATA PHARMACEUTICALS INCMarch 07, 20232,083,7996.5%
AGILE THERAPEUTICS INCSold outFebruary 14, 202300.0%
ALBIREO PHARMA, INC.February 14, 20231,757,1608.5%
BELLUS Health Inc.February 14, 20238,891,0277.1%
CinCor Pharma, Inc.February 14, 20232,576,3255.9%
Coherus BioSciences, Inc.Sold outFebruary 14, 202300.0%
CONCERT PHARMACEUTICALS, INC.February 14, 20231,800,0003.6%

View Perceptive Advisors's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D2024-03-20
SC 13G2024-03-14
SC 13G2024-03-11
SC 13G/A2024-03-06
SC 13D/A2024-03-01
SC 13G2024-03-01
SC 13D/A2024-02-29
13F-HR/A2024-02-26
SC 13G/A2024-02-23
42024-02-21

View Perceptive Advisors's complete filings history.

Compare quarters

Export Perceptive Advisors's holdings